Author: Sánchez-Montalvá, Adrián; Fernández-Naval, Candela; Antón, Andrés; Durà , Xavier; Vimes, Alba; Silgado, Aroa; Velásquez-Orozco, Fernando; Espinosa-Pereiro, Juan; Salvador, Fernando; Pumarola, Tomás; Almirante, Benito; Esperalba, Juliana
Title: Risk of SARS-CoV-2 Infection in Previously Infected and Non-Infected Cohorts of Health Workers at High Risk of Exposure Cord-id: boxmqtad Document date: 2021_5_4
ID: boxmqtad
Snippet: The objective of this study is to assess the risk of newly acquired RNA detection-proven SARS-CoV-2 infection after previous SARS-CoV-2 infection. This is a prospective study conducted from March to September 2020 in Barcelona, Spain. Healthcare workers caring for SARS-CoV-2 infected patients were divided in two cohorts: (a) previously RNA-proven SARS-CoV-2 infected cohort with mild symptoms (IC) and (b) healthy cohort (HC). Weekly SARS-CoV-2 RNA detection assays from nasopharyngeal swabs were p
Document: The objective of this study is to assess the risk of newly acquired RNA detection-proven SARS-CoV-2 infection after previous SARS-CoV-2 infection. This is a prospective study conducted from March to September 2020 in Barcelona, Spain. Healthcare workers caring for SARS-CoV-2 infected patients were divided in two cohorts: (a) previously RNA-proven SARS-CoV-2 infected cohort with mild symptoms (IC) and (b) healthy cohort (HC). Weekly SARS-CoV-2 RNA detection assays from nasopharyngeal swabs were performed. Serology status was assessed at the beginning and at the end of the study. Twenty participants were included in each group. The median age was 30 (IQR 27–34.75) years, and 55% were female. The median time of follow up was 49 (IQR 49–51) days. Fifteen out of 246 (6%) nasopharyngeal swab samples were positive for SARS-CoV-2, all in the IC. The percentage of participants in the IC with a probable newly acquired SARS-CoV-2 RNA-proven infection was 20% (95% IC 5.7–43.6%) at the end of the 7-week follow up period. The incidence reinfection rate was 28.6 (95% IC 7.8–73.2) cases per 1000 person-week. Despite detectable IgG antibodies against SARS-CoV-2 participants highly exposed to SARS-CoV-2 may develop a newly acquired SARS-CoV-2 RNA detection episode during the first months after the initial infection.
Search related documents:
Co phrase search for related documents- absolute number and additional information: 1
- absolute number and long immune response: 1
- absolute number and long period: 1, 2, 3, 4
- absolute number and long term persistence: 1
- acid amplification and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- acid amplification and additional case: 1
- acid amplification and additional information: 1
- acid amplification and long period: 1
- acute infection and additional case: 1, 2, 3, 4
- acute infection and additional information: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute infection and additional real time: 1
- acute infection and long immune response: 1, 2, 3, 4, 5, 6, 7
- acute infection and long period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- additional case and long period: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date